Complementary value of molecular, phenotypic, and functional aging biomarkers in dementia prediction

DNA methylation age (MA), brain age (BA), and frailty index (FI) are putative aging biomarkers linked to dementia risk. We investigated their relationship and combined potential for prediction of cognitive impairment and future dementia risk using the ADNI database. Of several MA algorithms, DunedinPACE and GrimAge2, associated with memory, were combined in a composite MA alongside BA and a data-driven FI in predictive analyses. Pairwise correlations between age- and sex-adjusted measures for MA (aMA), aBA, and aFI were low. FI outperformed BA and MA in all diagnostic tasks. A model including age, sex, and aFI achieved an area under the curve (AUC) of 0.94 for differentiating cognitively normal controls (CN) from dementia patients in a held-out test set. When combined with clinical biomarkers (apolipoprotein E ε4 allele count, memory, executive function), a model including aBA and aFI predicted 5-year dementia risk among MCI patients with an out-of-sample AUC of 0.88. In the prognostic model, BA and FI offered complementary value (both βs 0.50). The tested MAs did not improve predictions. Results were consistent across FI algorithms, with data-driven health deficit selection yielding the best performance. FI had a stronger adverse effect on prognosis in males, while BA's impact was greater in females. Our findings highlight the complementary value of BA and FI in dementia prediction. The results support a multidimensional view of dementia, including an intertwined relationship between the biomarkers, sex, and prognosis. The tested MA's limited contribution suggests caution in their use for individual risk assessment of dementia.

Authors

Institutions

Publication Details

Journal
GeroScience
Published
2024-10-24
DOI
https://doi.org/10.1007/s11357-024-01376-w
Citations
4
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
1.54

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Complementary value of molecular, phenotypic, and functional aging biomarkers in dementia prediction

Evan Fletcher, Stephen Salloway, Effie Mitsis, Pierre N. Tariot et al.
4 citations
GeroScience
Dementia and Cognitive Impairment Research
1.54
article

Complementary value of molecular, phenotypic, and functional aging biomarkers in dementia prediction

Evan Fletcher, Stephen Salloway, Effie Mitsis, Pierre N. Tariot, Lars Tjelta Westlye, Lawrence S. Honig, Clifford R. Jack, Brandy R. Matthews, Magdalena Korecka, Robert B. Santulli, John Olichney, Kristine Lipowski, Gregory A. Jicha, Maria T. Greig, Donna Munic, Dana Nguyen, Robert Bartha, Godfrey D. Pearlson, Richard E. Carson, Ann Marie Hake, Maria Carroll, Karen L. Bell, John Brockington, David Clark, Enchi Liu, Li Shen, Arthur W. Toga, Stephen Pasternak, Teresa Villena, Lisa Raudin, Danielle Harvey, Susan K. Schultz, Lisa Taylor Reinwald, Balebail Ashok Raj, Nick C. Fox, Kaycee M. Sink, Amanda Smith, S. J. Wolk, Gus Jiminez, Karen Crawford, Carl Sadowsky, Michelle Rainka, Raj C. Shah, Judith L. Heidebrink, Neil W. Kowall, Peggy Roberts, Marilyn Albert, Henry Rusinek, Allan I. Levey, Jerome A. Yesavage, Daniel D’Agostino, Karl Trygve Kalleberg, Kristin Fargher, Antero Sarrael, Lidia Glodzik, Andrew J. Saykin, Tamie Sather, Dzintra Celmins, Kenneth Spicer, Randall Griffith, Chester A. Mathis, Heather S. Anderson, Heather Johnson, Peter Hardy, Sonia Pawluczyk, Helen Vanderswag, Michael Donohue, Tom Montine, Yaakov Stern, Erin Householder, Joanne Lord, MaryAnn Oakley, Ronald Killiany, Sherye A. Sirrel, Susan De Santi, Anton P. Porsteinsson, Irina Rachinsky, Norman Relkin, Henry Querfurth, Dick Trost, Barton Lane, Alexander Norbash, Nunzio Pomara, Andrew E. Budson, Meghan Frey, Adrian Preda, Kathleen Tingus, Kim Martin, Daniel Silverman, Ronald G. Thomas, Jeffrey Kaye, Sandra E. Black, Liberty Teodoro, Howard Feldman, Sandra A. Jacobson, Cynthia Hunt, Bojana Stefanovic, Bonnie S. Goldstein, Prashanthi Vemuri, Norbert Schuff, Charles Bernick, Michal Figurski, Sarah Walter, Kris Johnson, Howard Bergman, Bruce L. Miller, Eric M. Reiman, Joseph Quinn, Maria Kataki, Ellen Woo, Russell Howard Swerdlow, Christina A. Michel, Matthew L. Senjem, Steven G. Potkin, Saba Wolday, Kristen Martin Cook, Jeff D. Williamson, Myron Weiner, Sara S. Mason, Brian R. Ott, Bret Borowski, Liana Apostolova, Geoffrey Tremont, Colleen S. Albers, Owen Carmichael, Karen Blank, Kelly M. Makino, Zaven Kachaturian, Gad A. Marshall, Gloria Chaing, Adam Fleisher, Neill R. Graff Radford, Kyle Womack, Javier Villanueva Meyer, Hillel Grossman, Partha Sinha, Lon S. Schneider, David S. Knopman, Laurel Beckett, Brigid Reynolds, Christine M. Belden, William J. Jagust, Ging‐Yuek Robin Hsiung, Andreas Engvig, Alan J. Lerner, John C. Morris, David Geldmacher, Stephen Correia, T. Y. Lee, Martha G. MacAvoy, Chuang Wu, Jeffrey Murray Burns, Chris Hosein, Michael Borrie, Rachelle S. Doody, Sue Leon, Sara Dolen, Daniel Varón, Michael D. Devous, Paula Ogrocki, Ramon Diaz Arrastia, Charles DeCarli, Joy L. Taylor, Howard J. Rosen, Elizabeth Finger, Stacy Schneider, Thomas O. Obisesan, Raymundo Hernando, Benita Mudge, George Bartzokis, Beau M. Ances, Mark A. Mintun, Kejal Kantarci, Scott Herring, Terence Z. Wong, Francine Parfitt, Brittany Cerbone, Andrew Kertesz, James J. Lah, Jeffrey R. Petrella, Connie Brand, Christopher H. van Dyck, Betty Lind, Tracy Kendall, Paul Malloy, Erik D. Roberson, Robert A. Koeppe, James E. Galvin, Elizabeth Oates, Sterling C. Johnson, Ranjan Duara, Matt A. Bernstein, Diana Kerwin, Susan Landau, Peter J. Snyder, Kwangsik Nho, Raymond Scott Turner, Raina Carter, Howard Chertkow, Steven Edward Arnold, Nancy Johnson, David Bachman, Cynthia M. Carlsson, Tamar J. Kitzmiller, Esten H. Leonardsen, Dana M. Pogorele, Douglas W. Scharre, Kewei Chen, Paul M. Thompson, Oscar L. López, Sungeun Kim, Leslie M. Shaw, Karen E. Smith, Walter Martínez, Robert C. Green, Chiadi Onyike, Michael Walter Weiner, Laura L. Boles Ponto, Stephanie Kielb, Mony J. de Leon, Marwan N. Sabbagh, Bryan M. Spann, Jason H. Karlawish, Pradeep Garg, Norm Foster, Sanjay Asthana, M. Saleem Ismail, Vernice Bates, Jared Tinklenberg, Nigel J. Cairns, Charles D. Smith, Janet S. Cellar, Eben S. Schwartz, Curtis Caldwell, Patricia Lynn Johnson, Tatiana M. Foroud, John Q. Trojanowski, Angela Oliver, Keith A. Johnson, Devon Gessert, Paul Aisen, Virginia Lee, Scott Neu, Joanne Allard, Susan Molchan, Smita Kittur, Alice D. Brown, James B. Brewer, Allyson Rosen, Richard King, Karen Anderson, Dick Drost, Ronald Petersen, Anahita Adeli, John Rogers, R.T. Frank, Mary Quiceno, Po H. Lu, Kathleen A. Johnson, Leon Hudson, Hyungsub Shim, Martin R. Farlow, Dana Mathews, P. Murali Doraiswamy, Stephanie Reeder, Munir Chowdhury, Horacio Capote, Gary Conrad, Susan Rountree, Marek Marsel Mesulam, Catherine Mc-Adams-Ortiz, Chad Ward, Reisa A. Sperling, Mauricio Becerra, Earl A. Zimmerman, Donna M. Simpson, Jeff Gunter, Ruth A. Mulnard, Leyla deToledo‐Morrell, Jacobo Mintzer, Franklin Watkins, Gaby Thai, Mimi Dang, Michele Assaly Past, Kelley Faber
article en
4 citations

Abstract

DNA methylation age (MA), brain age (BA), and frailty index (FI) are putative aging biomarkers linked to dementia risk. We investigated their relationship and combined potential for prediction of cognitive impairment and future dementia risk using the ADNI database. Of several MA algorithms, DunedinPACE and GrimAge2, associated with memory, were combined in a composite MA alongside BA and a data-driven FI in predictive analyses. Pairwise correlations between age- and sex-adjusted measures for MA (aMA), aBA, and aFI were low. FI outperformed BA and MA in all diagnostic tasks. A model including age, sex, and aFI achieved an area under the curve (AUC) of 0.94 for differentiating cognitively normal controls (CN) from dementia patients in a held-out test set. When combined with clinical biomarkers (apolipoprotein E ε4 allele count, memory, executive function), a model including aBA and aFI predicted 5-year dementia risk among MCI patients with an out-of-sample AUC of 0.88. In the prognostic model, BA and FI offered complementary value (both βs 0.50). The tested MAs did not improve predictions. Results were consistent across FI algorithms, with data-driven health deficit selection yielding the best performance. FI had a stronger adverse effect on prognosis in males, while BA's impact was greater in females. Our findings highlight the complementary value of BA and FI in dementia prediction. The results support a multidimensional view of dementia, including an intertwined relationship between the biomarkers, sex, and prognosis. The tested MA's limited contribution suggests caution in their use for individual risk assessment of dementia.

GeroScienceVol. 47(2)
Oslo University Hospital (NO), University of Oslo (NO)
Foundation for the National Institutes of Health, Bristol-Myers Squibb, Eli Lilly and Company, Biogen, BioClinica, Northern California Institute for Research and Education, Eisai, Universitetet i Oslo, H. Lundbeck A/S, IXICO, National Institutes of Health, Genentech, Canadian Institutes of Health Research
Good health and well-being
Openalex Percentile: Top 16%
Dementia and Cognitive Impairment Research
1.54
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.